Blocking MHC class II on human endothelium mitigates acute rejection.

Abrahimi, Parwiz; Qin, Lingfeng; Chang, William G; Bothwell, Alfred L M; Tellides, George; Saltzman, W Mark; Pober, Jordan S

Abrahimi, Parwiz; Qin, Lingfeng; Chang, William G; Bothwell, Alfred L M; Tellides, George; Saltzman, W Mark; Pober, Jordan S.

Afiliación

Abrahimi P; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
Qin L; Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA.
Chang WG; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Bothwell AL; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
Tellides G; Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA.
Saltzman WM; Department of Biomedical Engineering, Yale University School of Medicine, New Haven, Connecticut, USA.
Pober JS; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.

JCI Insight ; 1(1)2016.

Article en En | MEDLINE | ID: mdl-26900601

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JCI Insight Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google